Illustration for: Cerebras Is the Comp Every AI Listing Should Study

Cerebras Is the Comp Every AI Listing Should Study

Cerebras opened at $350 against a $185 price in May and is back at that offer price in September, which makes it the only completed public-market experiment in how AI compute businesses get valued after the narrative premium wears off.

By the Numbers

$185
Cerebras IPO price
$350
Day-1 open
$386.34 (May 14)
All-time high
$160.81
Late-June low
~$185-190
Early-Sept range
TC
By the IPO Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
2 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

Everyone quotes Cerebras opening at $350 against a $185 price and nobody quotes that it is flat to issue four months later. That round trip is the real comp for Crusoe, Nscale and every compute name behind them. The line I would underwrite on: backlog is not revenue. Ask what percentage of a $103 billion backlog carries a termination penalty, because that is the only part a public market will pay a multiple on.

Analysis

Cerebras priced at $185 in May, opened at $350, peaked at $386.34 on its first day, bottomed at $160.81 in late June, and now trades around $185 to $190 at roughly a $45 billion market cap. Four months, one complete circle.

That path is the most useful pricing document available to any AI compute company weighing a listing, and it is more instructive than the private marks those companies are currently carrying.

What the round trip actually tested

Cerebras sells AI accelerators and inference capacity -- a business whose revenue is concentrated in a small number of very large customers and whose cost base is capital equipment on a depreciation schedule. On day one the market priced the narrative. Over the following ninety days it repriced against reported earnings, and the answer it arrived at was: roughly the IPO price.

The private compute marks queued behind it were set on different logic:

  • Crusoe -- $30B: no public filing, bankers retained.
  • Fluidstack -- [$18B](/pulse/fluidstack-1-5-billion-jane-street-18-billion-valuation-2026), up from $7.5B in December 2025, on a round Jane Street led.
  • Nscale -- $30B cap against a $103B contract backlog.
  • SB Energy -- $439B backlog against $269M of revenue, per its Nasdaq registration.

Every one of those numbers is a forward claim on contracts, and the Cerebras experience is what happens when a public market gets to test a forward claim quarterly.

The distinction that will decide pricing

It is not compute versus applications. It is contracted versus committed. A backlog figure counts capacity a customer has agreed to buy; what a public market pays for is revenue a customer cannot walk away from without a penalty. Those are different documents, and the S-1 risk factors are where the difference shows up.

SpaceX offers the contrast, as Pulse laid out in its aftermarket scorecard: priced at $135 in June, closed day one near $161 -- a far smaller pop -- and has climbed since, with Oppenheimer raising its target to $280 on Sept. 2. A modest opening and a rising line is the shape issuers should want. The spike-and-round-trip is the shape that leaves employees underwater at the first lockup expiry, and it is the one the AI compute queue is currently priced for.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.